UTMD (STOCKS)
Utah Medical Products Inc
$68.370000
+1.220000 (+1.82%)
Prev close: $67.150000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Kevin Leighton Cornwell
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $217.38M
- Employees
- 167
- P/E (TTM)
- 19.28
- P/B (TTM)
- 1.79
- Dividend Yield
- 183.17%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $38.52M |
| Benefits Costs and Expenses | $24.41M |
| Cost Of Revenue | $16.52M |
| Costs And Expenses | $24.41M |
| Gross Profit | $22.00M |
| Operating Expenses | $10.60M |
| Research and Development | $668.00K |
| Other Operating Expenses | $9.93M |
| Operating Income/Loss | $11.40M |
| Income/Loss From Continuing Operations After Tax | $11.29M |
| Income/Loss From Continuing Operations Before Tax | $14.11M |
| Income Tax Expense/Benefit | $2.82M |
| Income Tax Expense/Benefit, Current | $3.44M |
| Income Tax Expense/Benefit, Deferred | -$614.00K |
| Net Income/Loss | $11.29M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $11.29M |
| Net Income/Loss Available To Common Stockholders, Basic | $11.29M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $3.48 |
| Diluted Earnings Per Share | $3.48 |
| Basic Average Shares | 3,240,000 |
| Diluted Average Shares | 3,240,000 |
| Assets | $122.54M |
| Current Assets | $97.74M |
| Inventory | $7.94M |
| Other Current Assets | $89.81M |
| Noncurrent Assets | $24.80M |
| Fixed Assets | $9.91M |
| Intangible Assets | $840.00K |
| Other Non-current Assets | $14.05M |
| Liabilities | $3.27M |
| Current Liabilities | $2.60M |
| Accounts Payable | $911.00K |
| Wages | $853.00K |
| Other Current Liabilities | $834.00K |
| Noncurrent Liabilities | $676.00K |
| Long-term Debt | $0.00 |
| Commitments and Contingencies | $0.00 |
| Equity | $119.27M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $119.27M |
| Liabilities And Equity | $122.54M |
| Net Cash Flow From Operating Activities | $14.69M |
| Net Cash Flow From Operating Activities, Continuing | $14.69M |
| Net Cash Flow From Investing Activities | -$371.00K |
| Net Cash Flow From Investing Activities, Continuing | -$371.00K |
| Net Cash Flow From Financing Activities | -$12.34M |
| Net Cash Flow From Financing Activities, Continuing | -$12.34M |
| Exchange Gains/Losses | $797.00K |
| Net Cash Flow | $2.78M |
| Net Cash Flow, Continuing | $1.98M |
| Comprehensive Income/Loss | $13.78M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $13.78M |
| Other Comprehensive Income/Loss | $2.49M |